Optune Gio
Payments companies reported to CMS as associated with Optune Gio. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Optune Gio, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Optune Gio
These are the largest totals companies reported as associated with Optune Gio. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Roger Stupp | Chicago, IL | Hematology & Oncology | $62,322.50 |
| Daniel Kim | Fairfax, VA | Radiation Oncology | $30,602.23 |
| Rimas Lukas | Chicago, IL | Hematology & Oncology | $29,647.28 |
| Suriya Jeyapalan | Boston, MA | Neurology (Psychiatry & Neurology) | $21,351.09 |
| Michael Lim | Stanford, CA | Neurological Surgery | $20,313.78 |
| David Tran | Los Angeles, CA | Medical Oncology | $19,230.30 |
| Samuel Goldlust | Kansas City, MO | Neurology (Psychiatry & Neurology) | $18,443.90 |
| Caroline Goldin | New Orleans, LA | Neurology (Psychiatry & Neurology) | $15,077.49 |
| Omar Butt | Saint Louis, MO | Medical Oncology | $14,847.72 |
| Ramji Rajendran | Elk Grove Village, IL | Radiation Oncology | $13,183.99 |
Prescribed Optune Gio?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.